Valmark Advisers, Inc.

Position in CVS — CVS HEALTH Corp

CIK 1380443 AKRON, OH

Position in CVS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$208,348

-$76,713 QoQ

Shares Held

2,014

-43.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,689

of 2,051 holders

Holding Since

Mar 2021

20 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Valmark Advisers, Inc. holds $3,295,977 across 4 Healthcare Plans names. CVS ranks #4 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UNH	Unitedhealth Group Inc	5,414	$2,250,220
2	ELV	Elevance Health, Inc.	1,254	$484,959
3	OSCR	Oscar Health, Inc.	12,358	$352,450
4	CVS	CVS HEALTH Corp This page	2,014	$208,348

20 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$208,348	2,014	-43.9%	Shares	Sole	2026-08-06
2025-12-31	$285,061	3,592	-3.8%	Shares	Sole	2026-01-26
2025-09-30	$281,430	3,733	+8.5%	Shares	Sole	2025-10-24
2025-06-30	$237,360	3,441	-23.8%	Shares	Sole	2025-07-23
2025-03-31	$305,891	4,515	-5.4%	Shares	Sole	2025-04-23
2024-09-30	$300,252	4,775	-6.1%	Shares	Sole	2024-10-25
2024-06-30	$300,320	5,085	-7.1%	Shares	Sole	2024-08-01
2024-03-31	$436,366	5,471	+31.6%	Shares	Sole	2024-05-06
2023-12-31	$328,315	4,158	-13.6%	Shares	Sole	2024-02-02
2023-09-30	$336,113	4,814	+10.4%	Shares	Sole	2023-11-08
2023-06-30	$301,406	4,360	-1.2%	Shares	Sole	2023-08-03
2023-03-31	$328,078	4,415	+6.0%	Shares	Sole	2023-05-02
2022-12-31	$388,322	4,167	+7.5%	Shares	Sole	2023-02-07
2022-09-30	$369,844	3,878	+1.5%	Shares	Sole	2022-11-03
2022-06-30	$353,961	3,820	+39.0%	Shares	Sole	2022-08-01
2022-03-31	$278,226	2,749	-2.0%	Shares	Sole	2022-05-10
2021-12-31	$289,363	2,805	+9.0%	Shares	Sole	2022-02-02
2021-09-30	$218,429	2,574	-10.0%	Shares	Sole	2021-11-09
2021-06-30	$238,638	2,860	+6.9%	Shares	Sole	2021-08-06
2021-03-31	$201,315	2,676	—	Shares	Sole	2021-05-04
No filing history on record for this holder in this stock.